logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
E

Enriqueta Felip

vall d’hebron institute of oncology

129H-index
1.5KPaper Count
11.1WCitation Count
Published Papers 397
Publication Date
logo
Lorlatinib in patients with ALK-positive metastatic NSCLC previously treated with an ALK inhibitor: results from a phase IV study
errFuture Oncology
IF2.6
err2026-04-08
err0
PREAI
errAlessandra Bearz; Serena Ricciardi; Nirmal Vivek Raut; Manuel Cobo Dols; Satheesh Chiradoni Thungappa; Paola Claudia Sacco; Holger Thurm; Dmitri Pavlov; Francesca Toffalorio; Enriqueta Felip
errShare
errSave
Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment
errGenome Medicine
IF11.2
err2026-04-01
err0
errOAAI
errIlaria Priano; Ramon Amat; Caterina Carbonell; Aina Arbusà-Roca; Patricia Iranzo; Nuria Pardo; Mireia Soleda; Gerard Romero-Sola; Barbara Sinigaglia; Sara Polo-Alonso; Ana Callejo; Augusto Valdivia; Pedro Rocha; Javier Hernandez-Losa; Marta Sese; Oriol Mirallas; Laura Masfarré; Susana Cedrés; Alex Martinez-Marti; Rocío Caro-Consuegra; Enriqueta Felip
errShare
errSave
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors
errESMO Open
IF8.3
err2025-11-06
err0
errOAAI
errR. Dienstmann; A. Vivancos; P. Nuciforo; S. Aguilar; F. Ruiz-Pace; C. Viaplana; J. Gonzalez; B. Fite; A. Pedrola; E. Elez; C. Saura; E. Felip; T. Macarulla; J. Capdevila; L. Fariñas-Madrid; J. Carles; J. Mateo; E. Muñoz-Cosuelo; J. Balmaña; I. Braña; E. Garralda; J. Tabernero
errShare
errSave
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS <50% and ≥50% Cohorts of the EVOKE-02 Study
errJournal of Thoracic Oncology
IF20.8
err2025-10-30
err0
PREAI
errMartin Reck; Jyoti D. Patel; Jhanelle E. Gray; Noemí Reguart; Manuel Cobo; José Fuentes Pradera; Enriqueta Felip; Federico Cappuzzo; Edward B. Garon; Joel W. Neal; Sabeen Mekan; Farnoush Safavi; Nelumka Fernando; Marianna Zavodovskaya; Juliane M. Jürgensmeier; Michael Chisamore; Byoung Chul Cho
errShare
errSave
A Time and Motion Study Comparing Subcutaneous Pembrolizumab Versus Intravenous Pembrolizumab in Combination with Chemotherapy for the Treatment of Metastatic Non-small Cell Lung Cancer
errAdvances in Therapy
IF4
err2025-10-21
err0
errOAAI
errErwin De Cock; Sabine Oskar; Cecilia Lourdudoss; Renata Eiras; M. Catherine Pietanza; Ashwini Arunachalam; Gustavo Alves; Gaston Lucas Martinengo; Enriqueta Felip
errShare
errSave
TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I NSCLC
errthoracic and cardiovascular surgery
IF0
err2025-09-19
err0
PREAI
errDavid R. Jones; Isabelle Opitz; David Harpole; Jane Yanagawa; Eric Lim; Yasuhiro Tsutani; Daniel S.W. Tan; Sanja Dacic; Apar Kishor Ganti; Shankar Bodla; Anastasiya Batig; Pavlo Lyfar; Alessandra Forcina; Enriqueta Felip
errShare
errSave
Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial
errJournal of Thoracic Oncology
IF20.8
err2025-09-09
err0
errOAAI
errByoung Chul Cho; Weimin Li; Alexander I. Spira; Maxwell Sauder; Jill Feldman; Farastuk Bozorgmehr; Milena Mak; Janellen Smith; Pei Jye Voon; Baogang Liu; Panwen Tian; Jiunn-Liang Tan; Cheng-Ta Yang; Jin-Yuan Shih; Nuri Karadurmus; Juan Esteban Cundom; Glaucio Bertollo; Irfan Cicin; Jorge Nieva; Ana Laura Ortega-Granados; Pascale Tomasini; Danny Nguyen; Enriqueta Felip; Julia Schuchard; Sean P. Murphy; Bailey G. Anderson; Tonatiuh Romero; Yichuan Xia; Shubin Sheng; Joshua M. Bauml; Parthiv J. Mahadevia; Julian Kam; Mehregan Nematian-Samani; Jairo Simoes; Mark Wildgust; Nicolas Girard
errShare
errSave
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-09-01
err9
PREAI
errYang, James Chih-Hsin; Lu, Shun; Hayashi, Hidetoshi; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Kim, Yu Jung; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang; Alip, Adlinda; Korbenfeld, Ernesto; Mourao Dias, Josiane; Besse, Benjamin; Passaro, Antonio; Lee, Ki-Hyeong; Xiong, Hailin; How, Soon-Hin; Cheng, Ying; Chang, Gee-Chen; Yoshioka, Hiroshige; Thomas, Michael; Nguyen, Danny; Ou, Sai-Hong Ignatius; Mukhedkar, Sanjay; Prabhash, Kumar; D'Arcangelo, Manolo; Alatorre-Alexander, Jorge; Vazquez Limon, Juan Carlos; Alves, Sara; Stroyakovskiy, Daniil; Peregudova, Marina; Sendur, Mehmet Ali Nahit; Yazici, Ozan; Califano, Raffaele; Gutierrez Calderon, Vanesa; de Marinis, Filippo; Kim, Sang-We; Gadgeel, Shirish M.; Owen, Scott; Xie, John; Sun, Tao; Mehta, Jaydeep; Venkatasubramanian, Raja; Ennis, Mariah; Fennema, Elizabeth; Daksh, Mahesh; Roshak, Amy; Man, Julie; Knoblauch, Roland E.; Bauml, Joshua M.; Baig, Mahadi; Shah, Sujay; Sethi, Seema; Cho, Byoung Chul
errShare
errSave
Off-label use of olaparib in uncommon tumor locations in patients with impaired homologous recombination genes
errFARMACIA HOSPITALARIA
IF1.3
err2025-09-01
err0
errOAAI
errGarcia-Diaz, Hector Carlos; Larrosa-Garcia, Maria; Gomez-Alonso, Javier; Cruellas, Mara; Felip, Enriqueta; Macarulla, Teresa; Farriols, Anna; Carreras, Maria J.
errShare
errSave
Intracranial activity of sotorasib vs docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer from a global, phase 3, randomized controlled trial
errLung Cancer
IF4.4
err2025-07-29
err0
errOAAI
errAnne-Marie C. Dingemans; Konstantinos Syrigos; Lorenzo Livi; Astrid Paulus; Sang-We Kim; Yuanbin Chen; Enriqueta Felip; Frank Griesinger; Kadoaki Ohashi; Gerard Zalcman; Brett G.M. Hughes; Jens Benn Sørensen; Normand Blais; Carlos G.M. Ferreira; Colin R. Lindsay; Rafal Dziadziuszko; Patrick J. Ward; Cynthia Chinedu Obiozor; Yang Wang; Solange Peters
errShare
errSave
Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts
errLung Cancer
IF4.4
err2025-07-10
err0
errOAAI
errNancee Pronsati; Geoffrey Liu; Todd M. Bauer; Enriqueta Felip; Yasushi Goto; Gerald Green; Mary Grizzard; Michael Hamel; Julien Mazieres; Tony Mok; Stephanie Snow; Benjamin J. Solomon; Jan Stratmann; Ken Culver
errShare
errSave
A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC
errJournal of Thoracic Oncology
IF20.8
err2025-06-12
err0
errOAAI
errMyung-Ju Ahn; Aaron Lisberg; Yasushi Goto; Jacob Sands; Min Hee Hong; Luis Paz-Ares; Elvire Pons-Tostivint; Maurice Pérol; Enriqueta Felip; Shunichi Sugawara; Hidetoshi Hayashi; Byoung Chul Cho; George Blumenschein; Elaine Shum; Jong-Seok Lee; Rebecca S. Heist; Robin Cornelissen; Wen-Cheng Chang; Dariusz Kowalski; Hong Zebger-Gong; Michael Chargualaf; Wen Gu; Lan Lan; Paul Howarth; Richard Joseph; Isamu Okamoto
errShare
errSave
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC—A Brief Report
errJournal of Thoracic Oncology
IF20.8
err2025-06-04
err0
errOAAI
errGregory J. Riely; Myung-Ju Ahn; Jeffrey M. Clarke; Ibiayi Dagogo-Jack; Raymond Esper; Enriqueta Felip; Francesco Gelsomino; Jonathan W. Goldman; Maen Hussein; Melissa Johnson; Kristen A. Marrone; Daniel Morgensztern; Ernest Nadal; Marcelo V. Negrao; Michael Offin; Mariano Provencio; Suresh S. Ramalingam; Logan Roof; Rachel E. Sanborn; Egbert F. Smit; Anne Tsao; Tiziana Usari; Ann Alcasid; Keith Wilner; Svitlana Tonkovyd; Xiaosong Zhang; Bruce E. Johnson
errShare
errSave
Plain language summary of the EVOKE-01 study of sacituzumab govitecan vs docetaxel in patients with non-small cell lung cancer
errFUTURE ONCOLOGY
IF2.6
err2025-05-15
err0
errOAAI
errLuis G Paz-Ares; Oscar Juan-Vidal; Giannis S Mountzios; Enriqueta Felip; Niels Reinmuth; Filippo de Marinis; Nicolas Girard; Vipul M Patel; Takayuki Takahama; Scott P Owen; Douglas M Reznick; Firas B Badin; Irfan Cicin; Sabeen Mekan; Riddhi Patel; Eric Zhang; Divyadeep Karumanchi; Marina Chiara Garassino
errShare
errSave
BAP1 Mutations and Pleural Mesothelioma: Genetic Insights, Clinical Implications, and Therapeutic Perspectives
errCANCERS
IF4.4
err2025-05-06
err0
errOAAI
errCedres, Susana; Valdivia, Augusto; Priano, Ilaria; Rocha, Pedro; Iranzo, Patricia; Pardo, Nuria; Martinez-Marti, Alex; Felip, Enriqueta
errShare
errSave
Plain language summary of first-line amivantamab-lazertinib in previously untreated high-risk EGFR-altered non-small-cell lung cancer in MARIPOSA
errFUTURE ONCOLOGY
IF2.6
err2025-04-24
err0
errOAAI
errFelip, Enriqueta; Cho, Byoung Chul; Lu, Shun; Sendur, Mehmet Ali Nahit; Gadgeel, Shirish M.; Sethi, Seema; Bauml, Joshua M.; Hayashi, Hidetoshi
errShare
errSave
Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy
errESMO OPEN
IF8.3
err2025-04-01
err0
errOAAI
errChiang, A. C.; Garcia, M. E. Olmedo; Carlisle, J. W.; Dowlati, A.; Reguart, N.; Felip, E.; Jost, P. J.; Steeghs, N.; Stec, R.; Gadgeel, S. M.; Loong, H. H.; Jiang, W.; Hamidi, A.; Parkes, A.; Paz-Ares, L.
errShare
errSave
Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary
errFUTURE ONCOLOGY
IF2.6
err2025-03-01
err0
errOAAI
errde Langen, Adrianus Johannes; Johnson, Melissa L.; Mazieres, Julien; Dingemans, Anne-Marie C.; Mountzios, Giannis; Pless, Miklos; Wolf, Juergen; Schuler, Martin; Lena, Herve; Skoulidis, Ferdinandos; Yoneshima, Yasuto; Kim, Sang-We; Linardou, Helena; Novello, Silvia; van der Wekken, Anthonie J.; Chen, Yuanbin; Peters, Solange; Felip, Enriqueta; Solomon, Benjamin J.; Ramalingam, Suresh S.; Dooms, Christophe; Lindsay, Colin R.; Ferreira, Carlos Gil; Blais, Normand; Obiozor, Cynthia C.; Wang, Yang; Mehta, Bhakti; Varrieur, Tracy; Ngarmchamnanrith, Gataree; Stollenwerk, Bjoern; Waterhouse, David; Paz-Ares, Luis
errShare
errSave
Debate on first-line treatment strategies in advanced non-small cell lung cancer with EGFR mutation: An expert panel meeting by the Italian Association of Thoracic Oncology (AIOT)
errLUNG CANCER
IF4.4
err2025-03-01
err0
PREAI
errGridelli, Cesare; Mok, Tony; Janne, Pasi; Passaro, Antonio; Felip, Enriqueta; Ramalingam, Suresh S.; Attili, Ilaria
errShare
errSave
Reply to the Letter to the Editor regarding 'PFS, OS or toxicity: what is the most important factor in the treatment of EGFR- mutated lung cancer?' by T. Nishimura and H. Fujimoto
errANNALS OF ONCOLOGY
IF65.4
err2025-02-01
err0
PREAI
errFelip, E.; Cho, B. C.; Nguyen, D.; Curtin, J. C.; Sethi, S.; Bauml, J. M.; Lee, S. H.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
P
Pasi A. Jänne
H-index: 163 · Papers: 2.3K
J
Josep Tabernero
H-index: 146 · Papers: 2.7K
J
James Chih‐Hsin Yang
H-index: 141 · Papers: 1.2K
Y
Yi‐Long Wu
H-index: 135 · Papers: 2.2K
T
Tony Mok
H-index: 131 · Papers: 1.1K
View more